Physician profile

Steven Beard

Dentist · Birmingham, AL

NPI 1902597701

$925.71

in general payments reported to CMS, 2019-2025

3 companies · $243 in 2025

The $243 reported for 2025 was more than what 80% of Dentist providers received nationally (typical 2025 total: $70.27).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$592.95
Food and Beverage$206.61
Gift$87.71
Honoraria$38.44

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Benco Dental Supply Co. $631.39 2024
Straumann USA LLC $267.54 2024-2025
Dentsply Sirona INC $26.78 2024 Atlantis

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven Beard

$925.71

in general payments reported 2019-2025

Years
2024-2025
Top company
Benco Dental Supply Co.
Context
The $243 reported for 2025 was more than what 80% of Dentist providers received nationally (typical 2025 total: $70.27).

https://glasscript.com/doctor/11472658/steven-beard

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.